PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
25.12
Positive P/E while Healthcare median is negative at -1.57. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
2.43
P/S less than half the Healthcare median of 7.57. Walter Schloss would verify if this discount reflects fixable issues. Check margins versus peers.
2.59
P/B 1.25-1.5x Healthcare median of 1.82. Guy Spier would scrutinize if premium reflects better asset utilization.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.59
Fair value ratio 1.25-1.5x Healthcare median of 1.84. Guy Spier would scrutinize if premium reflects durable advantages.
1.00%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
No Data
No Data available this quarter, please select a different quarter.